Gene therapy progress and prospects: Magnetic nanoparticle-based gene delivery

Gene Therapy

Volumn 13, Issue 4, 2006, Pages 283-287

  Dobson, J ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Gene delivery; Magnetic nanoparticles; Magnetofection

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; CARBON NANOTUBE; FERRIC OXIDE; NANOPARTICLE; POLYETHYLENEIMINE; PROTAMINE SULFATE; RETROVIRUS VECTOR; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE;

GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC FIELD; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; REPORTER GENE; REVIEW; THEORETICAL STUDY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; DRUG DELIVERY SYSTEMS; FORECASTING; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; MAGNETICS; NANOTUBES, CARBON; TRANSFECTION;

EID: 32444450342     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302720     Document Type: Review

References (16)

1. Pankhurst QA, Connoly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D 2003; 36: R167-R181.
2. Grief AD, Richardson G. Mathematical modelling of magnetically targeted drug delivery. J Magn Magn Mater 2005; 293: 455-463.
3. Neuberger T, Schopf B, Hofmann H, Hofmann M, von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J Magn Magn Mater 2005; 293: 483-496.
4. Harris LA, Goff JD, Carmichael AY, Riffle JS, Harburn JJ, St Pierre TG et al. Magnetite nanoparticle dispersions stabilized with triblock copolymers. Chem Mater 2003; 15: 1367-1377.
5. Yiu HPH, El Haj AJ, Dobson J. Novel iron oxide-silica nanostructured particles for cell biology. Vienna Magnetics Group Report 2005, 14-15 pp. ISBN 3-902105-00-1.
6. Yiu HPH, Dobson J, El Haj AJ. Internalization of functionalized magnetic nanoparticles into human cells with the use of DOTAP as a transfecting agent. Vienna Magnetics Group Report 2005, 176-177 pp. ISBN 3-902105-00-1.
7. Cai D, Mataraza JM, Qin ZH, Huang Z, Huang J, Chiles TC et al. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nature Methods 2005; 2: 449-454.
8. Morishita N, Nakagami H, Morishita R, Takeda S-i, Mishima F, Terazono B et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Comm 2005; 334: 1121-1126.
9. Plank C, Schillinger U, Scherer F, Bergemann C, Remy JS, Krotz F et al. The magnetofection method: Using magnetic force to enhance gene therapy. Biol Chem 2003; 384: 737-747.
10. Gersting SW, Schillinger U, Lausier J, Nicklaus P, Rudolph C, Plank C et al. Gene delivery to respiratory epithelial cells by magnetofection. J Gene Med 2004; 6: 913-922.
11. Krötz F, Sohn HY, Gloe T, Plank C, Pohl U. Magnetofection potentiates gene delivery to cultured endothelial cells. J Vasc Res 2003; 40: 425-434.
12. Schillinger U, Brill T, Rudolph C, Huth S, Gersting SW, Krötz F et al. Advances in magnetofection - magnetically guided nucleic acid delivery. J Magn Magn Mater 2005; 293: 501-508.
13. Krötz F, de Wit C, Sohn H-Y, Zahler S, Gloe T, Pohl U et al. Magnetofection - a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther 2003; 7: 700-710.
14. Krötz F, Engelbrecht B, Buerkle MA, Bassermann F, Bridell H, Gloe T et al. The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation. J Amer Coll Cardiol 2005; 45: 1700-1706.
15. Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, Welsch U et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med 2004; 6: 923-936.
16. Ferrari S, Griesenbach U, Shirai-Iida T, Shu T, Hironaka T, Hou X et al. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Therapy 2004; 11: 1654-1656.